Table 3. Competing risk regression models for the association between renal function at baseline and long-term risk of cancer diagnosis.

Sub-hazard ratio(SHR) for eGFR<60 mL/min/1.73m² compared to normal or slightly decreased GFR. eGFR estimated from CKD-EPI. Competing risk is death without cancer diagnosis.

	Unadjusted		Adjusted for smoking history and age
	SHR (95% CI)	P-value	SHR (95% CI)	P-value
Older men	0.80 (0.57, 1.12)	0.2	0.81 (0.58, 1.13)	0.2
Younger men	0.84 (0.64, 1.10)	0.2	0.80 (0.61, 1.06)	0.12
Older women	0.93 (0.77, 1.13)	0.5	0.92 (0.75, 1.12)	0.4
Younger women	0.91 (0.39, 2.14)	0.8	0.90 (0.39, 2.07)	0.8